Deletion of galectin‐3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1G93A mouse model of amyotrophic lateral sclerosis
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Galectins are pleiotropic carbohydrate‐binding lectins involved in inflammation, growth/differentiation, and tissue remodeling. The functional role of galectins in amyotrophic lateral sclerosis (ALS) is unknown. Expression studies revealed increases in galectin‐1 mRNA and protein in spinal cords from SOD1 G93A mice, and in galectin‐3 and ‐9 mRNAs and proteins in spinal cords of both SOD1 G93A mice and sporadic ALS patients. As the increase in galectin‐3 appeared in early presymptomatic stages and increased progressively through to end stage of disease in the mouse, it was selected for additional study, where it was found to be mainly expressed by microglia. Galectin‐3 antagonists are not selective and do not readily cross the blood–brain barrier; therefore, we generated SOD1 G93A/Gal‐3 −/− transgenic mice to evaluate galectin‐3 deletion in a widely used mouse model of ALS. Disease progression, neurological symptoms, survival, and inflammation were assessed to determine the effect of galectin‐3 deletion on the SOD1 G93A disease phenotype. Galectin‐3 deletion did not change disease onset, but resulted in more rapid progression through functionally defined disease stages, more severely impaired neurological symptoms at all stages of disease, and expiration, on average, 25 days earlier than SOD1 G93A/Gal‐3 +/+ cohorts. In addition, microglial staining, as well as TNF‐α, and oxidative injury were increased in SOD1 G93A/Gal‐3 −/− mice compared with SOD1 G93A/Gal‐3 +/+ cohorts. These data support an important functional role for microglial galectin‐3 in neuroinflammation during chronic neurodegenerative disease. We suggest that elevations in galectin‐3 by microglia as disease progresses may represent a protective, anti‐inflammatory innate immune response to chronic motor neuron degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140 · cited 2×
“Expression of galectin-3, also known as Mac-2, correlates with microglial activation subsequent to neuronal degeneration in mouse models of ALS (Yamanaka et al. 2008; Saxena et al., 2009; Hossiani et al. 2011), but nevertheless, its role in the disease is unclear.”
BackgroundResultNon–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008 · cited 1×
“Sporadic and familial forms of ALS share common pathophysiological features, including a marked neuroinflammatory response, characterized by glial activation and innate and adaptive inflammatory components (for reviews, see Ilieva et al. 2009 and Appel et al. 2011).”
BackgroundSelective Ablation of Proliferating Microglial Cells Exacerbates Ischemic Injury in the Brain
Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y. C., & Kriz, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5360-06.2007 · Cited by 874
Inflammatory processes in amyotrophic lateral sclerosis
McGeer, P. L., & McGeer, E. G. (2002) · Muscle & Nerve · doi:10.1002/mus.10191 · Cited by 470
Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function
Pasquini, L. A., Millet, V, Hoyos, H. C., Giannoni, J. P., Croci, D. O., Marder, M., Liu, F. T., Rabinovich, G. A., & Pasquini, J. M. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.40 · Cited by 152
Self-citation
Cited by
Alternatively activated microglia and macrophages in the central nervous system
Franco, R., & Fernández-Suárez, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.003 · Cited by 650
Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis
Frakes, A. E., Ferraiuolo, L., Haidet-Phillips, A. M., Schmelzer, L., Braun, L., Miranda, C. J., Ladner, K. J., Bevan, A. K., Foust, K. D., Godbout, J. P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.013 · Cited by 638
“, 2001) and in some cases have even hastened disease progression (Lerman et al., 2012), highlighting the complexity of neuroinflammation in ALS.”
Burguillos, M. A., Svensson, M., Schulte, T., Boza-Serrano, A., Garcia-Quintanilla, A., Kavanagh, E., Santiago, M., Viceconte, N., Oliva-Martin, M. J., Osman, A. M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.012 · Cited by 365
“In neuroinflammatory models of ALS, Gal3 can induce an anti-inflammatory response (Lerman et al., 2012), whereas in experimental autoimmune encephalomyelitis, Gal3 can exacerbate the disease by reinforcing the inflammatory response (Jiang et al.”
BackgroundInfluentialTargeting mi R‐155 restores abnormal microglia and attenuates disease in SOD 1 mice
Butovsky, O., Jedrychowski, M. P., Cialic, R., Krasemann, S., Murugaiyan, G., Fanek, Z., Greco, D. J., Wu, P. M., Doykan, C. E., Kiner, O., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24304 · Cited by 358
“Deletion of galectin-3, which is induced in an anti-inflammatory (M2) microglia phenotype,(16) exacerbates microglial activation and accelerates disease progression in a SOD1 mouse model.(17) We previously reported that there is recruitment of Ly6C peripheral inflammatory monocytes to the spinal cord of SOD1 mice and…”
Untangling the brain’s neuroinflammatory and neurodegenerative transcriptional responses
Srinivasan, K., Friedman, B. A., Larson, J. L., Lauffer, B. E., Goldstein, L. D., Appling, L. L., Borneo, J., Poon, C., Ho, T., Cai, F., et al. (2016) · Nature Communications · doi:10.1038/ncomms11295 · Cited by 336
Metadata
- Authors
- Lerman, B. J., Hoffman, E. P., Sutherland, M. L., Bouri, K., Hsu, D. K., Liu, F., Rothstein, J. D., & Knoblach, S. M.
- Venue
- Brain and Behavior
- Publisher
- Wiley
- Published
- 2012-07-23
- Volume
- 2
- Issue
- 5
- Pages
- 563-575
- ISSN
- 2157-9032 (ISSN-L)
- 2162-3279
- OpenAlex
- W2028298072
- Cited by
- 88
- References
- 7
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deletion of galectin‐3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1G93A mouse model of amyotrophic lateral sclerosis. https://app.cochat.ai/papers/10.1002/brb3.75
- The paper
- Lerman, B. J., Hoffman, E. P., Sutherland, M. L., Bouri, K., Hsu, D. K., Liu, F., Rothstein, J. D., & Knoblach, S. M. (2012). Deletion of galectin‐3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1G93A mouse model of amyotrophic lateral sclerosis. Brain and Behavior. https://doi.org/10.1002/brb3.75
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.